Imagine a world where groundbreaking medical discoveries are no longer happening in the U. S.  This is a real possibility if the National Institutes of Health (NIH) goes ahead with its plan to slash funding for research infrastructure.  This funding is crucial for universities and research institutions to conduct their work.  Without it, the U. S. could lose its edge as a global leader in scientific innovation.

The NIH's new policy, announced in February 2025, aims to cap indirect costs at 15% across all grants.  This might sound like a good idea, as it would mean more money goes directly to research.  However, it could have serious consequences.  Indirect costs cover a lot more than just administration.  They include maintaining labs, paying for utilities, and ensuring safety and compliance with regulations.  These costs are substantial and unavoidable.  They are essential for creating and maintaining the environment where scientific breakthroughs can happen.

The NIH spent over $35 billion on grants in 2023.  Of this, approximately $9 billion was allocated to indirect costs.  This money supports more than 300, 000 researchers at over 2, 500 institutions.  Without it, many institutions would struggle to keep their research infrastructure running.  This could lead to a significant drop in the quality and quantity of research being done.

The new policy could also lead to a significant loss of funding for states.  For example, Texas could lose over $310 million, and California could lose over $800 million.  This could have a devastating impact on the research institutions in these states.

The NIH has compared its new 15% cap to the rates set by private foundations.  However, many researchers and funders have criticized this comparison as misleading.  Private foundations often set low indirect cost rates because their grants make up a small portion of an institution's funding.  In contrast, NIH grants cover a significant portion of an institution's overhead costs.  This allows institutions to accept foundation grants with low indirect rates.

Scientists and researchers have responded to the NIH's announcement with deep concern.  They worry that the funding cuts could significantly damage U. S. biomedical research.  The Council on Governmental Relations has urged the NIH to rescind the policy, stating that "America’s competitors will relish this self-inflicted wound. "  The Association of American Medical Colleges has also expressed concern, stating that the policy could "diminish the nation’s research capacity, slowing scientific progress and depriving patients, families, and communities across the country of new treatments, diagnostics and preventative interventions. "

The future of scientific research in the U. S. hangs in the balance.  How institutions adapt and whether the NIH reconsiders its approach will determine the outcome.  It's a critical time for U. S. science, and the decisions made now could have long-lasting effects.

Cutting the Lifeline: How Slashing Research Funds Could Stunt U. S. Innovation

Actions